John Osborn
October 6, 2022 12:02 AM EDTUpdated 06:54 AM
People

UK en­vi­ron­men­tal ini­tia­tive taps a big name in ad­ver­tis­ing to lead US ef­forts

Nicole DeFeudis

Editor

As the phar­ma in­dus­try buck­les down to re­duce its car­bon foot­print — with some com­mit­ting to ze­ro emis­sions as ear­ly as 2025 — so is the ad­ver­tis­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times